Eli Lilly says next-generation weight loss drug clears crucial obesity trial

CNBCMay 21, 2026 at 11:40 AM

The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

markets

These 4 market sectors look frothy — and Nvidia’s isn’t even the biggest bubble

MarketWatchMay 23, 2026 at 4:52 PM

markets

The surprising cost of caring for aging parents: Divorce

MarketWatchMay 23, 2026 at 5:44 PM

markets

Your bond portfolio is facing a ‘termite’ infestation far worse than Jamie Dimon’s ‘cockroaches’

MarketWatchMay 23, 2026 at 5:58 PM

← Back to all articles

Related Articles

These 4 market sectors look frothy — and Nvidia’s isn’t even the biggest bubble

The surprising cost of caring for aging parents: Divorce

Your bond portfolio is facing a ‘termite’ infestation far worse than Jamie Dimon’s ‘cockroaches’